The symptoms often follow a pattern where: Many patients report improvement in nausea and malaise after the first few weeks Symptoms often become more manageable or resolve completely with continued treatment Some patients may experience mild symptoms that persist longer, though these typically become less bothersome over time Factors affecting duration: Several variables influence how long symptoms persist: Dose escalation schedule slower titration (gradual dose increases) typically results in fewer and shorter-lasting symptoms Individual sensitivity some patients are more susceptible to gastrointestinal side effects Concurrent medications other drugs affecting the GI tract may prolong symptoms Dietary habits eating patterns and food choices can influence symptom severity and duration It is worth noting that symptoms may temporarily recur when the dose is increased according to the recommended schedule (which varies by product weekly for liraglutide, every 4 weeks for weekly semaglutide), but subsequent episodes are often less severe than the initial experience

Prolyl oligopeptidase inhibition attenuates steatosis in the L02 human liver cell line
The mechanism involves glucose-dependent insulin secretion, meaning insulin release occurs primarily when blood glucose levels are elevated, thereby reducing the risk of hypoglycemia when used as monotherapy
Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-hispanic, black women
Dalle Grave, R
Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK